Expand BBP Menu
BBP MENU

BBP ETF Profile


Family: Virtus ETF Solutions
Name: Virtus LifeSci Biotech Products ETF
Inception Date: 17-Dec-2014
Termination Date:
Investment Objective: Virtus LifeSci Biotech Products ETF (the "Products Fund") is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the performance of the LifeSci Biotechnology Products Index. Products stage companies are typically more established companies with much clinical trial failure risk behind them.
Prospectus
Top 10 Holdings
Viking Therapeutics Inc VKTX 2.9768%
Alpine Immune Sciences Inc ALPN 2.9379%
Avidity Biosciences Inc RNA 2.5224%
Vera Therapeutics Inc VERA 2.3379%
Spyre Therapeutics Inc SYRE 1.9885%
Apogee Therapeutics Inc APGE 1.9055%
Cullinan Oncology Inc CGEM 1.8072%
Dyne Therapeutics Inc DYN 1.8051%
Sana Biotechnology Inc SANA 1.7806%
Liquidia Corp LQDA 1.6353%
Top 10 Holdings Weight: 21.7%
Number of Holdings: 104
Shares Outstanding: 350,004
Total Net Assets: 17,710,200
NAV: 50.97
Net Expense Ratio: 0.79%
Asset Class: Equities (Stocks)
Developed or Emerging: Developed Market Funds
Country: US
Region:
Strategy:
Currency:
Commodity:
Sector: Healthcare
Industry: Biotech
Dividend Type:
Tax Exempt State:
Maturity Duration:
Market Cap: Broad Market / Multi-Cap
Credit Quality:
Mortgage Bond Types:
Bond Type:
Gov't Bond Types:
Reit Type:
Leverage Direction/Factor:
Is Currency Hedged: No
US or Ex-US: Domestic